Study on the effectiveness of ligand reversible shielding
strategy in targeted delivery and tumor therapy
Hu, ZP (Hu, Zhenpeng)[ 1 ] ; Li, XM (Li, Xiaomin)[ 1 ] ; Yuan, M (Yuan, Ming)[ 1 ] ; Wang, XY (Wang, Xinyu)[ 1 ] ; Zhang, YP (Zhang, Yapei)[ 1 ] ; Wang, W (Wang, Wei)[ 1 ] ; Yuan, Z (Yuan, Zhi)[ 1,2 ]
ACTA BIOMATERIALIA, 2019, 83: 349-358
DOI: 10.1016/j.actbio.2018.11.021
Abstract
We
previously proved the superiority of the ligand reversible shielding strategy
based on the pH responsive self-assembly/disassembly of gold nanoparticles
through computed tomography imaging in vivo. Herein, the practicality of this
strategy in tumor therapy was investigated by a ligand reversible shielding
system based on a temperature-responsive polymer. The ligand biotin,
cisplatin-loaded chain poly(acrylic acid)-Pt, and the shielding segment
thermo-sensitive poly(N-isopropylacrylamide-co-acryla mide) (P(NIPAAm-co-AAm))
were co-modified onto the surface of gold nanostars. In the blood circulation
(37 degrees C), the ligand was shielded by the extension of P(NIPAAm-co-AAm),
whose lower critical solution temperature (LCST) is approximately 39 degrees C.
After the nanoparticles accumulate at the tumor site by the enhanced
permeability and retention (EPR) effect, the heat generated from gold nanostars
upon near-infrared light irradiation would trigger the contraction of
P(NIPAAm-co-AAm), thus deshielding the ligand for enhanced tumor cellular
uptake. Owing to the reversible extension-contraction transformation change of
P(NIPAAm-co-AAm), the reversible shielding effect on the ligand could be
accomplished even if the nanoparticles return to the blood circulation. The
results indicated that the system could extend blood circulation (1.6-fold at
24 h), reduce immune system clearance (28% lower), and enhance tumor
accumulation (37% higher) effectively compared with the irreversible ligand
shielding system by analysis of platinum. This strategy showed significantly
superior tumor inhibition (11% higher) than the irreversible system. All these
results make clear that the ligand reversible shielding strategy is effective
and offers important references for the design of nanomaterials for improving
tumor accumulation. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd.
All rights reserved.